US$ 27.31
tirzepatide effect on kidneys GLP therapies have established themselves as kidney-protective in type 2 diabetes and high risk of kidney disease. This new post-hoc analysis of SURPASS-CVOT's kidney outcomes shows greater kidney protection with (#mounjaro) Renal effects of GLP-1 receptor
Description
Conclusions To summarize, this study confirms the short-term psychiatric safety of GLP-1 RA, showing a negative association with suicidal behaviors (adjusted OR, 0.62

Minimal weight loss expected (0-2 lbs)

Sometimes supplementation is needed to ensure normal elimination while on these medications

PI3K as a pathway is sort of like the growth and survival pathway while the AMPK pathway acts sort of as a cellular version of a solar panel attached to a battery

Use a fresh needle every time
Sometimes, a medication may not cause depression right away
